子宫内膜异位症患者在接受激素替代治疗冻融胚胎移植周期中从高血清孕酮水平获益:一项队列研究
该队列研究纳入179名子宫内膜异位症患者的262个激素替代治疗冻融胚胎移植周期,采用阴道孕酮凝胶联合肌注孕酮支持。总体活产率为39%,最佳血清孕酮阈值为118 nmol/l(37.1 ng/ml),阈值以上组活产率51%显著高于阈值以下组34%,校正后活产比值比为2.1(95% CI 1.2至3.7)。
要点
- 子宫内膜异位症患者激素替代冻融胚胎移植中,血清孕酮≥118 nmol/l组活产率51%,低于该阈值组34%。
- 校正年龄、BMI、囊胚评分等后,活产比值比为2.1(95% CI 1.2至3.7)。
- 总体阳性HCG率60%,活产率39%,总妊娠丢失率34%。
核心结论
- 血清孕酮水平高于118 nmol/l(37.1 ng/ml)的患者活产率显著高于低于该水平者,提示存在最佳血清孕酮阈值。
研究设计与样本
- 队列研究,纳入179名经腹腔镜或超声诊断子宫内膜异位症患者的262个激素替代治疗冻融胚胎移植周期。
- 预处理为口服避孕药42天及5天洗脱期,随后每日口服雌激素6 mg。
- 当子宫内膜厚度≥7 mm时开始阴道孕酮凝胶90 mg/12小时,从阴道孕酮第4天起加用肌注孕酮50 mg/日,孕酮第6天移植囊胚。
主要发现
- 总体阳性HCG率60%,活产率39%,总妊娠丢失率34%。
- 最佳血清孕酮阈值为118 nmol/l(37.1 ng/ml),定义为约登指数最大值。
- 未校正活产率在孕酮≥118 nmol/l组为51%(44/86),低于118 nmol/l组为34%(59/176),P=0.01。
- 校正年龄、体质量指数、囊胚评分、囊胚年龄、质量及移植囊胚数后,活产比值比为2.1(95% CI 1.2至3.7)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the optimal serum progesterone cut-off level in patients with endometriosis undergoing hormone replacement therapy frozen embryo transfer (HRT-FET) with intensive progesterone luteal phase support? DESIGN: A cohort study, including 262 HRT-FET cycles in 179 patients all diagnosed with endometriosis either by laparoscopy or by ultrasound in patients with visible endometriomas. Pre-treatment consisted of 42 days of oral contraceptive pills and 5 days' wash-out, followed by 6 mg oral oestrogen daily. Exogenous progesterone supplementation with vaginal progesterone gel 90 mg/12h commenced when the endometrium was 7 mm or thicker. From the fourth day of vaginal progesterone supplementation, patients also received intramuscular progesterone 50 mg daily. Blastocyst transfer was scheduled for the sixth day of progesterone supplementation. RESULTS: The overall positive HCG, live birth (LBR) and total pregnancy loss rates were 60%, 39% and 34%, respectively. The optimal progesterone cut-off level was 118 nmol/l (37.1 ng/ml) defined as the maximum of the Youden index. The unadjusted LBR was significantly higher in patients with progesterone measuring 118 nmol/l or above compared with patients with progesterone measuring less than 118 nmol/l (51% [44/86] versus 34% [59/176], P = 0.01), whereas the adjusted odds ratio for a live birth was 2.1 (95% CI 1.2 to 3.7) after adjusting for age, body mass index, blastocyst score, blastocyst age, quality and number of blastocysts transferred. CONCLUSIONS: Serum progesterone levels above 118 nmol/l (37.1ng/ml) resulted in significantly higher LBR compared with lower serum progesterone levels, suggesting that a threshold for optimal serum progesterone exists.
引用
- Alsbjerg B, Kesmodel US, Humaidan P, et al. Endometriosis patients benefit from high serum progesterone in hormone replacement therapy-frozen embryo transfer cycles: a cohort study. Reprod Biomed Online. 2022. PMID: 36216661. doi:10.1016/j.rbmo.2022.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。